Position in ALNY
as of Jun 30, 2026
· filed Jul 21, 2026
Position Value
$2,358,269
-$239,722 QoQ
Shares Held
7,834
-0.2% QoQ
Ownership
0.006%
of shares outstanding
% of Portfolio
0.15%
of 13F equity value
Holder Rank
#313
of 780 holders
Holding Since
Jun 2025
5 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in ALNY Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026ST GERMAIN D J CO INC holds $2,837,885 across 9 Biotechnology names. ALNY ranks #1 (83.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ALNY |
Alnylam Pharmaceuticals, Inc.
This page
|
7,834 | $2,358,269 | |
| 2 | BEAM |
Beam Therapeutics Inc.
|
3,500 | $120,120 | |
| 3 | TSHA |
Taysha Gene Therapies, Inc.
|
14,133 | $96,245 | |
| 4 | CORT |
Corcept Therapeutics Inc
|
1,000 | $86,950 | |
| 5 | JAZZ |
Jazz Pharmaceuticals plc
|
324 | $78,074 | |
| 6 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
148 | $73,516 | |
| 7 | LGND |
Ligand Pharmaceuticals Inc
|
75 | $23,706 | |
| 8 | MRNA |
Moderna, Inc.
|
10 | $700 |
All Filings in ALNY
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,358,269 | 7,834 | Shares | Sole | 2026-07-21 | |
| 2026-03-31 | $2,597,991 | 7,852 | Shares | Sole | 2026-04-13 | |
| 2025-12-31 | $3,124,336 | 7,857 | Shares | Sole | 2026-01-29 | |
| 2025-09-30 | $3,716,856 | 8,151 | Shares | Sole | 2025-10-07 | |
| 2025-06-30 | $2,932,853 | 8,994 | Shares | Sole | 2025-07-16 | |
| No filing history on record for this holder in this stock. | ||||||